Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response

Miao Yu, Dorothea Terhorst-Molawi, Sabine Altrichter, Tomasz Hawro, Y.-J. Chen, Il-Yeol Song, Chenglin Zhao, Marcus Maurer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)730-734
Number of pages4
JournalClinical and Experimental Allergy
Issue number5
DOIs
Publication statusPublished - May 2021

Fields of science

  • 302087 Venereology
  • 302011 Dermatology

Cite this